About Cosmos Pharmaceuticals
Cosmos Pharmaceuticals is a private company based in Middletown, Delaware. It has reported $1,150,000 raised in three offerings on Form D since February 2021. Its chief executive is Alexander Colton.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 22, 2025 | Oct 7, 2025 | $750,000of $1.2M target | 14 | $53,571 | EquityRule 506(b) | Form D ↗ |
| May 31, 2022 | Jun 3, 2022 | $175,000of $300K target | 7 | $25,000 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 8, 2020 | Feb 23, 2021 | $225,000of $250K target | 7 | $32,143 | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $1,150,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cosmos Pharmaceuticals's Form D filed Oct 7, 2025.
JW
Joseph White
Executive officer and director
AC
Alexander Colton
Chief Executive Officer and director
PM
Philip McBride
Executive officer
BE
Bart Edmunds
Director
CC
Christian Colton
Director